Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 2,786.66 | 611.46 | 440.00¢ | 30.3 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,194.42 | 855.33 | 656.05¢ | 20.3 | 0.4 | +49% | n/a | 0.0% |
31-Dec-27 | 3,573.75 | 1,102.16 | 816.43¢ | 16.3 | 0.7 | +24% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Also | 24-Jun-2006 | LA Times |
Also | 17-May-2006 | LA Times |
F.D.A. Demurs on Sleep Drug by Neurocrine | 17-May-2006 | New York Times |
Currency | US Dollars |
Share Price | $ 135.27 |
Change Today | $ 2.04 |
% Change | 1.53 % |
52 Week High | $152.81 |
52 Week Low | $93.25 |
Volume | 211,245 |
Shares Issued | 91.27m |
Market Cap | $12,346m |
RiskGrade | 225 |
Strong Buy | 11 |
Buy | 11 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 26 |
Time | Volume / Share Price |
14:31 | 100 @ $135.27 |
14:31 | 100 @ $135.21 |
14:30 | 100 @ $135.21 |
14:30 | 100 @ $135.18 |
14:30 | 100 @ $135.18 |
You are here: research